Open AccessPurpuric Drug Eruptions Caused by Epidermal Growth Factor Receptor Inhibitors for Non–Small Cell Lung Cancer
Author(s) -
YungTsu Cho,
Kai-Lung Chen,
YiShuan Sheen,
Che-Wen Yang,
JauYu Liau,
YuPin Cheng,
ChiaYu Chu
Publication year - 2017
Publication title -
jama dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.128
H-Index - 166
eISSN - 2168-6084
pISSN - 2168-6068
DOI - 10.1001/jamadermatol.2017.0903
Subject(s) - medicine , epidermal growth factor receptor , lung cancer , drug , dermatology , cancer research , cancer , pathology , pharmacology
Purpuric skin lesions have only rarely been reported in patients receiving epidermal growth factor receptor inhibitors. However, their clinical and histopathologic presentations have varied considerably.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom